Home
Conditions
Dyslipidemias

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

1,810 public trials 143 recruiting studies

Refine in advanced search Browse all conditions

Dyslipidemias trial results

Completed

Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol

NCT03400800

Conditions: ASCVD, Dyslipidemias, Elevated Cholesterol, +6 more
Locations: Research Site 11420-002 Chomutov, Czechia

Research Site 11420-003 Uherské Hradiště, Czechia

Research Site 11049-006 Berlin, Germany

Research Site 11049-002 Bochum, Germany

View all 70 locations

View Trial Details

Completed

Study of Gemcabene in Adults With FPLD

NCT03508687

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Dyslipidemias, +18 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)

NCT03361501

Conditions: Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
Locations: Research site Birmingham, Alabama, United States

Research site Childersburg, Alabama, United States

Research site Encino, California, United States

Research site Long Beach, California, United States

View all 68 locations

View Trial Details

Completed

Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg

NCT04511000

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Korea University Ansan Hospital Ansan, South Korea

Sejong General Hospital Bucheon-si, South Korea

Dong-A University Hospital Busan, South Korea

Inje University Ilsan Paik Hospital Goyang, South Korea

View Trial Details

Completed

Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz

NCT01695954

Conditions: Dyslipidemias, HIV, Hyperlipidemia, +4 more
Locations: Bellevue/NYU AIDS Clinical Trials Unit New York, United States

View Trial Details

Completed

Open-Label Extension of Study R727-CL-1003 (NCT01266876) to Evaluate the Long-Term Safety and Efficacy of Alirocumab (REGN727) in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)

NCT01576484

Conditions: Dyslipidemias, Heterozygous Familial Hypercholesterolemia, Hypercholesterolemia, +4 more
Locations: Mission Viejo, California, United States

Newport Beach, California, United States

Thousand Oaks, California, United States

Miami, Florida, United States

View all 14 locations

View Trial Details

Completed

Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2)

NCT03074630

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +7 more
Locations: Academic Medical Center Amsterdam, North Holland, Netherlands

View Trial Details

Completed

Effects of Use of a Connected Pillbox On Medication Adherence

NCT02593032

Conditions: Cardiovascular Diseases, Diabetes Mellitus, Dyslipidemias, +9 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Treatment Rates and Compliance to Treatment in Patients With Familial Hypercholesterolemia

NCT04494464

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations: Not specified

View Trial Details

Completed

Effect of Diabetes Mellitus on Cholesterol Metabolism

NCT00879710

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +12 more
Locations: Medical College of Wisconsin /Froedtert Hospital Milwaukee, Wisconsin, United States

View Trial Details

Dyslipidemias

Dyslipidemias trial results

Related conditions